Bronchopulmonary Dysplasia
📧 Sign up to get email alerts when something new happens for Bronchopulmonary Dysplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-02-05Clinical Trial Update: 129Xe MRI in Pediatric Population With BPD [Phase 1]
A Phase 1 trial evaluating 129Xe MRI in pediatric patients with Bronchopulmonary Dysplasia has been withdrawn. No results are reported due t…
-
EMA withdrawal · 2025-11-25EMA Application withdrawn: Hydrocortisone Aguettant (hydrocortisone) — Laboratoire Aguettant
The European Medicines Agency has withdrawn the marketing authorization application for Hydrocortisone Aguettant (hydrocortisone) by Laborat…
-
CLINICAL_TRIALS withdrawal · 2025-08-22Clinical Trial Update: Inhaled Treatment for Bronchopulmonary Dysplasia [Phase 1]
A Phase 1 inhaled treatment trial for bronchopulmonary dysplasia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-05-07Clinical Trial Update: Fast Assessment of Surfactant Deficiency in Preterm Infants to Speed up Treatment [NA]
A clinical trial investigating a fast assessment for surfactant deficiency in preterm infants to speed up treatment has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-07-24Clinical Trial Update: Rate of Bronchopulmonary Dysplasia in Preterms Neonates: a Trial Comparing SMOFlipid and Medialipide [Phase 4]
Phase 4 trial comparing SMOFlipid and Medialipide in preterm neonates was withdrawn from the study status.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2017-05-16EMA Application withdrawn: Blectifor (Caffeine citrate) — Viridian Pharma Ltd
The EMA withdrew the application for Blectifor (caffeine citrate) by Viridian Pharma in relation to bronchopulmonary dysplasia.
-
CLINICAL_TRIALS withdrawal · 2016-02-25Clinical Trial Update: TINN2: Treat Infection in NeoNates 2 [Phase 3]
A Phase 3 trial named TINN2 (Treat Infection in Neonates 2) investigating treatment for bronhopulmonary dysplasia in neonates has been withd…
-
CLINICAL_TRIALS withdrawal · 2011-12-30Clinical Trial Update: Phase 1 Intravenous Citrulline for the Prevention of Bronchopulmonary Dysplasia in Preterm Infants [Phase 1]
A Phase 1 clinical trial of intravenous citrulline to prevent bronchopulmonary dysplasia in preterm infants has been withdrawn.